Importantly, PI3K expression was reduced to a greater extent in the Tumor+100 mg/kg melatonin-treated group, whereas, AKT expression was markedly reduced in the tumor and 50 mg/kg melatonin-treated group. Here, AKT1 is linked to neoplasm.